Waleed Alsalhi1, Antonella Tosti2. 1. Department of Dermatology, College of Medicine, Majmaah University, Al-Majmaah, Saudi Arabia. 2. Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Abstract
INTRODUCTION: Klinefelter syndrome (KS) is defined as (a chromosomal disorder in which males have an extra X chromosome). KS presents clinically with signs of androgen deficiency including low testosterone. Androgenetic alopecia (AGA) develops as a response of the hair follicle cells to androgens in individuals with genetic predisposition. CASE PRESENTATION: We describe a 17-year-old male patient with KS who developed AGA with a Ludwig pattern. CONCLUSION: Our patient had a good response to oral minoxidil, finasteride, and low-level light therapy.
INTRODUCTION: Klinefelter syndrome (KS) is defined as (a chromosomal disorder in which males have an extra X chromosome). KS presents clinically with signs of androgen deficiency including low testosterone. Androgenetic alopecia (AGA) develops as a response of the hair follicle cells to androgens in individuals with genetic predisposition. CASE PRESENTATION: We describe a 17-year-old male patient with KS who developed AGA with a Ludwig pattern. CONCLUSION: Our patient had a good response to oral minoxidil, finasteride, and low-level light therapy.
Authors: Valerie M Harris; Rohan Sharma; Joshua Cavett; Biji T Kurien; Ke Liu; Kristi A Koelsch; Astrid Rasmussen; Lida Radfar; David Lewis; Donald U Stone; C Erick Kaufman; Shibo Li; Barbara Segal; Daniel J Wallace; Michael H Weisman; Swamy Venuturupalli; Jennifer A Kelly; Marta E Alarcon-Riquelme; Bernardo Pons-Estel; Roland Jonsson; Xianglan Lu; Jacques-Eric Gottenberg; Juan-Manuel Anaya; Deborah S Cunninghame-Graham; Andrew J W Huang; Michael T Brennan; Pamela Hughes; Ilias Alevizos; Corinne Miceli-Richard; Edward C Keystone; Vivian P Bykerk; Gideon Hirschfield; Gang Xie; Katherine A Siminovitch; Wan-Fai Ng; Gunnel Nordmark; Sara Magnusson Bucher; Per Eriksson; Roald Omdal; Nelson L Rhodus; Maureen Rischmueller; Michael Rohrer; Marie Wahren-Herlenius; Torsten Witte; Xavier Mariette; Christopher J Lessard; John B Harley; Kathy L Sivils; R Hal Scofield Journal: Clin Immunol Date: 2016-04-22 Impact factor: 3.969